casefind
fast
avail
effici
fontlin
diagnost
editor
delight
read
enlighten
letter
titl
global
threat
need
better
diagnost
tool
submit
archiv
medic
research
would
like
add
point
complementari
content
initi
letter
regard
better
diagnost
tool
worldwid
main
rational
behind
recent
advanc
develop
diagnost
achiev
fast
cheap
initi
detect
confirm
infect
differ
biolog
sampl
includ
fecal
sampl
nasopharyng
oropharyng
swab
environment
sampl
present
clinic
test
reli
mostli
reversetranscript
quantit
polymeras
chainreact
rtpcr
mani
countri
includ
develop
countri
viral
genom
sequenc
even
electron
microscopi
reportedli
use
confirmatori
test
follow
pcr
test
imag
test
ct
scan
clinic
test
use
monitor
establish
patient
clinic
us
food
drug
administr
recent
allow
emergencyus
author
abbot
newest
coronaviru
test
read
posit
result
neg
result
within
min
respect
fda
also
grant
licens
cepheid
assay
mesa
biotech
test
test
reportedli
made
avail
point
care
hospit
physician
offic
us
test
may
take
time
massproduc
approv
allow
develop
develop
countri
mesa
biotech
test
also
base
pcr
reportedli
moreov
mani
serologybas
assay
also
introduc
last
month
expedit
diagnosi
especi
expos
develop
antibodi
undoubtedli
scientif
experiment
advanc
go
unnot
publichealth
author
worldwid
decisionmak
direct
advanc
guidanc
experiment
advanc
take
time
becom
mainstream
routin
clinic
test
initi
diagnosi
infect
present
import
aim
fight
pandem
effici
casefind
variou
region
allow
determin
exact
number
infect
individu
allow
better
manag
control
pandem
howev
casefind
may
limit
develop
countri
scarc
number
diagnost
kit
relat
equip
addit
fragil
health
system
financi
difficulti
hamper
undertak
rapid
casefind
project
develop
countri
arguabl
rel
low
statist
case
develop
countri
may
mere
result
unavail
test
kit
thu
provid
rapid
accur
cheap
diagnost
kit
effici
help
health
author
develop
countri
expedit
casefind
within
popul
propos
test
kit
provid
freeli
low
cost
region
high
risk
viral
transmiss
undoubtedli
benefit
far
outweigh
kit
price
per
person
conclus
progress
rapid
diagnost
use
high
number
test
undertaken
survey
popul
either
countri
suspici
cluster
within
countri
diagnost
approach
includ
rtpcr
crisprbas
sherlock
specif
highsensit
enzymat
report
unlock
techniqu
homebas
pointofcar
test
tool
serolog
test
definit
help
casefind
throughout
world
becom
avail
appli
routin
test
fast
pace
scientif
experiment
advanc
arena
wait
may
long
fight
front
line
present
pandem
fund
receiv
manuscript
none
author
potenti
conflict
interest
